Table 3 Baseline characteristics of living donors regarding adverse events
From: Long-term impact of baseline serum uric acid levels on living kidney donors: a retrospective study
|  | All donors (n = 183) | Donors without adverse events(n = 139) | Donors with adverse events(n = 44) | p value |
|---|---|---|---|---|
Sex: male (%) | 65 (35.3) | 47 (33.8) | 18 (40.9) | 0.391 |
Age (years) | 58 [51–65] | 58 [50–65] | 59 [53–65] | 0.497 |
Tobacco use, n (%) | Â | Â | Â | 0.07 |
 Non-smoker | 102 (55.7) | 80 (57.6) | 22 (50.0) |  |
 Current smoker | 32 (17.5) | 21 (15.1) | 11 (25.0) |  |
 Ex-smoker | 17 (9.3) | 16 (11.5) | 1 (2.3) |  |
Height (cm) | 159 [154–166] | 159 [154–166] | 160 [154–166] | 0.467 |
Weight (kg) | 59.0 [52.0–66.1] | 57.0 [50.9–65.0] | 64.6 [55.3–74.2] | < 0.001 |
BMI (kg/m2) | 22.9 [20.9–25.1] | 22.1 [20.7–24.7] | 24.4 [22.6–27.4] | < 0.001 |
BP (mmHg) | 124 [115–136] | 122 [112–130] | 137 [125–147] | < 0.001 |
HbA1c (%) | 5.6 [5.4–5.9] | 5.6 [5.4–5.9] | 5.7 [5.5–6.0] | 0.153 |
UA (mg/dl) | 4.9 [4.2–5.7] | 4.8 [4.0–5.5] | 5.2 [4.5–6.7] | 0.001 |
LDL (mg/dl) | 120 [102–138] | 117 [99–132] | 135 [115–164] | < 0.001 |
CCr (ml/min) | 106.5 [95.3–121.4] | 107.3 [95.3–122.5] | 106.0 [93.5–120.7] | 0.712 |
preoperative eGFR (ml/min/1.73 m2) | 81.1 [73.0–91.8] | 81.1 [72.7–92.2] | 82.1 [74.9–89.2] | 0.971 |